Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-02-21Clinical Trial Update: Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage [Phase 2]
Phase 2 trial evaluating tranexamic acid to reduce post-surgical drainage after bilateral mastectomy for breast cancer with BRCA mutation ha…
-
CLINICAL_TRIALS withdrawal · 2025-01-24Clinical Trial Update: Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201 [Phase 1]
The Phase 1 trial of AB-201 for breast cancer, gastric cancer, and gastroesophageal junction adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-05Clinical Trial Update: Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors [Phase 2, Phase 3]
A Phase 2/3 study evaluating motivational enhancement therapy to improve adherence to aromatase inhibitors in breast cancer has been withdra…
-
CLINICAL_TRIALS withdrawal · 2024-11-26Clinical Trial Update: Feasibility and Effectiveness of a Sleep Hygiene Education Program for Sleep Issues in Breast Cancer Survivors [NA]
A clinical trial evaluating a sleep hygiene education program for sleep issues in breast cancer survivors has been withdrawn. The study, spo…
-
CLINICAL_TRIALS withdrawal · 2024-11-26Clinical Trial Update: Effectiveness of Aquatic Exercise on Fatigue, Neuropathy and Quality of Life Among Cancer Patients [NA]
A clinical trial evaluating aquatic exercise for fatigue, neuropathy, and quality of life in colon and breast cancer patients has been withd…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-11-26Clinical Trial Update: Feasibility and Effectiveness of an Internet-based Intervention to Manage Fatigue in Breast Cancer Survivors [NA]
The clinical trial NCT04160182 examining an internet-based intervention to manage fatigue in breast cancer survivors has been withdrawn. Spo…
-
CLINICAL_TRIALS withdrawal · 2024-11-25Clinical Trial Update: Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
A Travera Inc clinical trial (NCT04985357) evaluating mass response as a biomarker for tumor sensitivity to drugs has been withdrawn; no res…
-
CLINICAL_TRIALS withdrawal · 2024-11-19Clinical Trial Update: Brief Intervention for Tobacco and Alcohol Risk Reduction for Couple During Breast Cancer Treatment. [NA]
A clinical trial aiming to reduce tobacco and alcohol risk among couples during breast cancer treatment has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: Integrated Imaging System for In Vivo Visualization of Free Flap Perfusion Using Indocyanine Dye [NA]
A clinical trial evaluating an integrated imaging system with indocyanine dye for visualizing free flap perfusion in breast reconstruction h…
-
CLINICAL_TRIALS withdrawal · 2024-11-04Clinical Trial Update: Molecular Neuroimaging to Assess the Link Between Neuroinflammation and Cognitive Impairment in Breast Cancer [Phase 1]
A Phase 1 study evaluating molecular neuroimaging to link neuroinflammation with cognitive impairment in breast cancer has been withdrawn.
-
EMA withdrawal · 2024-10-24EMA Withdrawn: Onbevzi (bevacizumab) — Samsung Bioepis NL B.V.
The EMA has withdrawn the marketing authorization for Onbevzi (bevacizumab) by Samsung Bioepis NL B.V., across multiple cancer indications. …
-
CLINICAL_TRIALS withdrawal · 2024-10-22Clinical Trial Update: A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care [Phase 2]
Phase 2 feasibility and acceptability pilot trial evaluating a patient-specific targeted intervention using patient navigators versus routin…
-
CLINICAL_TRIALS withdrawal · 2024-10-16Clinical Trial Update: Laser Treatment of Genito-urinary Syndrome in Women [NA]
A clinical trial investigating laser treatment for genitourinary syndrome of menopause in women has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-04Clinical Trial Update: Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT) [NA]
The NCT01960803 trial evaluating lumpectomy followed by intraoperative electron radiation therapy for invasive ductal carcinoma of the breas…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: TAS-116 Plus Palbociclib in Breast and Rb-null Cancer [Phase 1]
A Phase 1 trial investigating TAS-116 in combination with palbociclib for advanced breast cancer and RB-deficient solid tumors has been with…
-
CLINICAL_TRIALS withdrawal · 2024-08-23Clinical Trial Update: Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating disitamab vedotin with toripalimab for hormone receptor-positive, HER2-low breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-21Clinical Trial Update: Music Therapy in Patients With Breast Cancer- a Randomized Controlled Trial [NA]
A randomized controlled trial evaluating music therapy in breast cancer patients with anxiety and fatigue has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-21Clinical Trial Update: Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer [NA]
Clinical trial evaluating vitamin B12 for aromatase inhibitor–associated musculoskeletal symptoms in hormone receptor-positive breast cancer…
-
CLINICAL_TRIALS withdrawal · 2024-08-13Clinical Trial Update: Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors [Phase 1, Phase 2]
A phase 1/2 trial evaluating TNG348 alone and in combination with a PARP inhibitor for BRCA1/2-mutant or HRD-positive solid tumors has been …
-
CLINICAL_TRIALS withdrawal · 2024-08-09Clinical Trial Update: Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors [EARLY_Phase 1]
A Phase 1 trial evaluating phytocannabinoids for chemotherapy-induced peripheral neuropathy in breast and colon cancer survivors has been wi…
-
CLINICAL_TRIALS withdrawal · 2024-08-07Clinical Trial Update: Phytoestrogens and Breast Cancer - Effects of Phytoestrogens on Markers of Disease Progression and Gene Expression [NA]
The clinical trial investigating the effects of phytoestrogens on markers of disease progression and gene expression in breast cancer has be…
-
CLINICAL_TRIALS withdrawal · 2024-07-18Clinical Trial Update: A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
The Phase 1 trial of GNC-035, a tetra-specific antibody, for locally advanced or metastatic solid tumors has been withdrawn. Breast cancer w…
-
CLINICAL_TRIALS withdrawal · 2024-06-12Clinical Trial Update: Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care [NA]
The clinical trial evaluating acupuncture and Chinese herbal medicine in palliative care for cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-21Clinical Trial Update: Efficacy of MR-HIFU Ablation of Breast Cancer [NA]
A clinical trial evaluating MR-HIFU ablation for breast cancer has been withdrawn (NCT02407613; sponsor UMC Utrecht; status: withdrawn).
-
CLINICAL_TRIALS withdrawal · 2024-05-10Clinical Trial Update: Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study [NA]
A feasibility study evaluating hypnosis for pain in Black women with advanced breast cancer has been withdrawn.